This CME conference will offer a comprehensive summary of new medications and clinical data pertaining to the management and treatment of atherosclerosis.

Atherosclerotic cardiovascular disease is a common problem which may begin early in life and progress as a person ages. The atherosclerotic condition involves lipid deposition of the arterial wall, which involves the immune system, inflammatory mediators, and the endothelial system. Over time, if developing atherosclerosis is left untreated, it may be progressive and can result in several dangerous and life-threatening cardiovascular conditions including myocardial infarction, carotid artery disease and stroke, among others. While atherosclerosis can often be prevented through good lifestyle choices including proper diet and exercise, a number of therapeutic options are available for patients where lifestyle changes may not be enough.

 EDUCATIONAL OBJECTIVES

• Identify cardiac risk factors and estimation of patients’ clinical risk.
• Explain mechanism and indication of PCSK9 inhibitors and omega 3 fish oil.
• Summarize mechanism and indication of SGL2 inhibitors as well as GLP1 agonists’ mechanisms of action and cite indications for use.
• Describe the cardiovascular benefits associated with diet and exercise modifications.
• Assess cardiac CT scoring and utility of coronary CTA.
• Illustrate polygenetic risk scoring in primary prevention of atherosclerotic cardiovascular disease.

ACCREDITATION

Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Scripps Health designates this live internet activity for a maximum of 5.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.